We Are Passionate

about women’s health and wellness

About Viveve

Viveve Medical is a medical technology company focused on women’s intimate health. Our mission is to enhance women’s lives by providing clinically proven, non-invasive, high quality products that improve their quality of life.

The Viveve® System is a dual-energy platform device. It incorporates Cryogen-cooled Monopolar Radiofrequency technology (CMRF) to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session. Viveve’s endovaginal procedure is performed in 45 minutes and requires no anesthesia to maintain patient comfort.
 

What Sets US Apart?

Internationally patented technology

Viveve has a strong, protected intellectual property portfolio of U.S. and International patents for its Cryogen-cooled Monopolar Radiofrequency (CMRF) dual energy technology platform and its use in vaginal tissue. Recently, a new U.S. Method Patent for Stress Urinary Incontinence was issued to further strengthen the Company’s IP portfolio.

Enthusiastic acceptance worldwide

The Viveve System is currently used by physicians and women’s healthcare practitioners in over 50 countries worldwide. In the United States, the Viveve System is approved for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances include its use for vaginal laxity and/or improvement of sexual function and/or improvement of stress urinary incontinence in women.

Worldwide acceptance

Robust clinical science

Scientific rigor in conducting clinical trials to prove safety and efficacy of our technology is foundational to Viveve. Large, multicenter, randomized, and blinded clinical trials conducted following U.S. and International regulatory agency requirements is Viveve’s tradition. Sound clinical studies provide evidence that demonstrates the effectiveness of a medical device to safely treat a specific medical condition. Viveve is continuing its commitment to robust science with initiation of its U.S. pivotal PURSUIT trial for improvement of stress urinary incontinence in women. Stress urinary incontinence is a condition that effects an estimated 25 – 30 million women worldwide.

Vision

Enhance women’s lives by providing clinically proven, non-invasive, high-quality products that improve their quality of life.

Find a Viveve Solutions Provider

Become a 
Provider

Translate »